Dual inhibition of IGF-1R and ErbB3 enhances the activity...

  • Main
  • 2018 / 03
  • Dual inhibition of IGF-1R and ErbB3 enhances the activity...
Clinical Cancer Research 2018 / 03

Dual inhibition of IGF-1R and ErbB3 enhances the activity of gemcitabine and nab-paclitaxel in preclinical models of pancreatic cancer

Camblin, Adam J, Pace, Emily A, Adams, Sharlene, Curley, Michael D., Rimkunas, Victoria, Nie, Lin, Tan, Gege, Bloom, Troy, Iadevaia, Sergio, Baum, Jason, Minx, Charlene, Czibere, Akos, Louis, Chrystal
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-17-2262
Date:
March, 2018
File:
PDF, 14.15 MB
english, 2018
Conversion to is in progress
Conversion to is failed